To read this content please select one of the options below:

Generic utilization and cost-sharing for prescription drugs

Pharmaceutical Markets and Insurance Worldwide

ISBN: 978-1-84950-716-5, eISBN: 978-1-84950-717-2

Publication date: 25 March 2010

Abstract

Purpose – The purpose of this study is to estimate the own- and cross-price elasticity of brand-name outpatient prescription drug cost-sharing for maintenance medications and to estimate the effects of changes in the price differential between generic and brand-name prescription drugs.

Methodology/approach – We first review the literature on the effects of an increase in brand-name drug patient cost-sharing. In addition, we analyze two examples of utilization patterns in filling behavior associated with an increase in brand-name cost-sharing for patients in employer-sponsored health plans with chronic illness.

Findings – We found that the own-price elasticity of demand for brand-name prescription drugs was inelastic. However, the cross-price elasticity was not consistent in sign, and utilization patterns for generic prescription fills did not always increase after a rise in brand-name cost-sharing.

Research limitations – The empirical examples are limited to the experience of patients with employer-sponsored health insurance.

Practical implications – The common practice of increasing brand-name prescription drug patient cost-sharing to increase consumption of generic drugs may not always result in higher generic medication use. Higher brand-name drug cost-sharing levels may result in discontinuation of chronic therapies, instead of therapeutic switching.

Originality/value of chapter – The value of this chapter is its singular focus on the effects of higher brand-name drug cost-sharing through a synthesis of the literature examining the own- and cross-price elasticity of demand for brand-name medications and two empirical examples of the effects of changes in brand-name cost-sharing.

Citation

Bernard Gibson, T., McLaughlin, C.G. and Smith, D.G. (2010), "Generic utilization and cost-sharing for prescription drugs", Dor, A. (Ed.) Pharmaceutical Markets and Insurance Worldwide (Advances in Health Economics and Health Services Research, Vol. 22), Emerald Group Publishing Limited, Leeds, pp. 195-219. https://doi.org/10.1108/S0731-2199(2010)0000022012

Publisher

:

Emerald Group Publishing Limited

Copyright © 2010, Emerald Group Publishing Limited